BSE filing, BSE: 544811. Summary written from the filing by ALFA Finder's alert engine.
Kratikal Tech Ltd: key numbers
- Share price
- ₹159.95
- Market cap
- ₹177.6 Cr
- Revenue (annual)
- ₹36.72 Cr
- Net profit (annual)
- ₹6.14 Cr
- P/E (TTM)
- 28.9×Sector 23.4×
- Promoter holding
- 53.40%
- FII holding
- 0.03%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kratikal Tech Ltd
All →Kratikal Tech H1 FY27 Results: Net Profit ₹2.8 Cr, Up 133.3% YoY
Kratikal Tech Ltd reported revenue from operations of ₹22.3 Cr (+65.2% YoY) and net profit of ₹2.8 Cr (+133.3% YoY) for H1 FY27.
- Key figure
- Net profit ₹2.8 Cr · +133.3% YoY
Kratikal Tech Board Meeting Date
Kratikal Tech will hold a board meeting on 05 Nov 2026 to consider half-year unaudited results. Trading window stays closed until 48 hours after declaration.
Kratikal Tech Other Announcement
Kratikal Tech Ltd has filed its quarterly shareholding pattern as per SEBI regulations. This is a periodic compliance disclosure with no material event impact.
Kratikal Tech Merger & Restructuring Worth ₹0.1 Cr
Kratikal Tech Ltd incorporated a wholly-owned subsidiary, Kratikal AI Inc., in Delaware, USA, as an SPV for cybersecurity operations with a USD 10,000 investment.
- Value
- ₹0.10 Cr
Kratikal Tech Other Announcement
Kratikal Tech Limited has appointed GoIndia Advisors LLP to provide investor relations management services, effective October 08, 2026, to strengthen its investor engagement framework.
Kratikal Tech Employee Stock Options
Kratikal Tech Ltd announced the grant of 17,996 employee stock options to eligible employees under its 2019 ESOP plan.
Other other announcement announcements
All →Kiri Industries Other Announcement
Kiri Industries filed the Crisil monitoring agency report for the quarter ended September 30, 2026. The report covers utilisation of preferential warrant issue proceeds with no deviations.
Sahajanand Medical Technologies Other Announcement
Sahajanand Medical Technologies appointed Amit Jaste & Associates as Secretarial Auditor for 60 months, effective 5 November 2026. Approved at the same-day board meeting.
- Execution
- 60 months
Dr. Agarwals Health Care Other Announcement
Dr. Agarwal's Health Care submitted ICRA's monitoring agency report for the quarter ended September 30, 2026. ICRA reports no material deviation in IPO proceeds utilisation.
Span Divergent Other Announcement
Span Divergent approved leasing Ahmedabad property to material subsidiary Dryfruit Factory LLP. Rent is capped at ₹3 lakh monthly under an arm's-length related-party transaction.
Cello World Other Announcement
Cello World's QIP monitoring report shows no fund deviation for the quarter ended September 2026. Object 1 is delayed, with Rs.1.51 crore unutilised.
Finkurve Financial Services Other Announcement
Finkurve Financial Services filed its Regulation 52(7) statement on use of Rs. 26 crore from its NCD issue, quarter ended September 2026. The statement reports no deviation or variation in use of proceeds.